March 09, 2021
1 min read
Save
Teva launches generic version of Azopt in US
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Teva Pharmaceuticals USA has launched the first generic version of Azopt in the United States.
The generic version of Azopt (brinzolamide ophthalmic suspension) 1% offers another treatment option for patients with ocular hypertension or open-angle glaucoma to lower elevated pressure in the eye by decreasing fluid, according to a press release.
“Continuing to pursue much-needed generic drugs is critical to ensuring access to quality medicines to everyone who needs them,” Christine Baeder, senior vice president, chief operating officer of US Generics, Teva USA, said in the release.
Published by:
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.